Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention.

Sandeep Khosla, Binu Kunjummen, Mayra Guerrero, Ravi Manda, Mansoor Razminia, Atul Trivedi, Vasundhara Vidyarthi, Monther Elbazour, Aziz Ahmed, David Lubell

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of combined use of low molecular weight heparin (enoxaparin, lovenox) and glycoprotein IIb/IIIa receptor antagonist (eptifibatide, integrelin) during nonemergent coronary and peripheral vascular intervention.'. Together they form a unique fingerprint.

Medicine & Life Sciences